Previous 10 | Next 10 |
MARIETTA, Ga., May 08, 2020 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (OTC PINK: MDXG) (“MiMedx” or “the Company”), an industry leader in advanced wound care and an emerging therapeutic biologics company, today announced that it is repaying the Payment Protection Pr...
MARIETTA, Ga., May 05, 2020 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (OTC PINK: MDXG) (“MiMedx” or “the Company”), an industry leader in advanced wound care and an emerging therapeutic biologics company, today announced the appointment of William L. Phelan as Senio...
Last week, Morgan Stanley analysts found that public companies had received $243.4M from the original Paycheck Protection Program, but that figure has now ballooned as additional firms file disclosures. More news on: Ashford Hospitality Trust, Inc., Braemar Hotels & Resorts, Inc., Fr...
MARIETTA, Ga., April 21, 2020 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (OTC PINK: MDXG) (“MiMedx” or “the Company”), an industry leader in advanced wound care and an emerging therapeutic biologics company, today announced that it has received notice from Bank of Am...
Drawing the curtain on another long-running issue, MiMedx ( OTC:MDXG +6.2% ) has finalized a settlement with the U.S. Department of Justice related to the accuracy of its commercial pricing disclosures to the U.S. Department of Veterans Affairs pertaining to one of its products listed on...
MARIETTA, Ga., April 06, 2020 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (OTC PINK: MDXG) (“MiMedx” or the “Company”), an industry leader in advanced wound care and an emerging therapeutic biologics company, today announced that it has finalized a settlement with the...
MARIETTA, Ga. , March 19, 2020 /PRNewswire/ -- MiMedx Group, Inc. (OTC PINK: MDXG) ("MiMedx" or "the Company"), an industry leader in advanced wound care and an emerging therapeutic biologics company, today announced that Peter M. Carlson , Executive Vice President of Finance, has b...
Finally moving ahead after its lengthy legal and financial reporting troubles, MiMedx ( OTC:MDXG ) has filed its 2018 annual report, including audited financial statements for 2017 and 2018 and restated results for 2016. More news on: MiMedx Group, Inc., Healthcare stocks news, Earnings ...
MARIETTA, Ga. , March 17, 2020 /PRNewswire/ -- MiMedx Group, Inc. (OTC PINK: MDXG) ("MiMedx" or "the Company"), an industry leader in advanced wound care and an emerging therapeutic biologics company, today announced the filing of its 2018 Annual Report, which includes the Company's ...
MARIETTA, Ga. , Dec. 16, 2019 /PRNewswire/ -- MiMedx Group, Inc. (OTC PINK: MDXG) ("MiMedx" or "the Company"), an industry leader in advanced wound care and an emerging therapeutic biologics company, today announced the addition of Peter M. Carlson as Executive Vice President, Finance, ...
News, Short Squeeze, Breakout and More Instantly...
Study adds to the Company’s growing body of evidence and expands the understanding of the regulatory capabilities of its DHACM and LHACM allografts on the fibrotic process Marks MIMEDX’s first publication in the 5 th most-cited journal in the world MARIET...
Rick Barry appointed Executive Chairman of the Board Remi Barbier resigns as President and CEO and from the Board of Directors Cassava initiates search for a new CEO AUSTIN, Texas, July 17, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA) today announced that the Boa...
MARIETTA, Ga., July 17, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the second quarter ended June 30, 2024 after the market close on Wednesday, July 3...